Pain Management Center of Paducah, Paducah, KY, USA.
Pain Physician. 2012 Sep-Oct;15(5):371-84.
BACKGROUND: Lumbar spinal stenosis is one of the most common causes of low back pain among older adults and can cause significant disability. Despite its prevalence, there is a paucity of literature concerning the treatment of spinal stenosis symptoms. Multiple interventions, including surgery and interventional techniques such as epidural injections and adhesiolysis, are commonly utilized in managing pain related to central spinal stenosis. However, there is a paucity of literature from randomized, controlled trials about the effectiveness of epidural injections for lumbar central spinal stenosis. OBJECTIVE: This study sought to assess the effectiveness of caudal epidural injections with or without steroids in providing effective and long-lasting pain relief for the management of chronic low back pain related to lumbar central stenosis. STUDY DESIGN: A randomized, double-blind, active-controlled trial. METHODS: One hundred patients were randomly assigned to one of 2 groups, with Group I patients receiving caudal epidural injections of local anesthetic (lidocaine 0.5%), whereas Group II patients received caudal epidural injections with 0.5% lidocaine 9 mL mixed with 1 mL of steroid, 6 mg (non-particulate betamethasone). OUTCOMES ASSESSMENT: Multiple outcome measures, including the Numeric Rating Scale (NRS), the Oswestry Disability Index 2.0 (ODI), employment status, and opioid intake were utilized. Assessments were carried out at 3, 6, 12, 18, and 24 months posttreatment. The primary outcome was defined as pain relief and improvement in disability scores of 50% or more. Successful treatment was considered as at least 3 weeks of relief following the first 2 injections, categorizing these patients into a successful group, and others into a failed group. RESULTS: Significant pain relief and functional status improvement were seen in 51% in Group I and 57% in Group II at the end of 2 years in the successful group when the participants were separated into successful and failed groups. However, overall, significant pain relief and functional status improvement (≥ 50%) was demonstrated in 38% in Group I and 44% in Group II at the end of 2 years. The overall number of procedures for 2 years were 4 in both groups, with 5 procedures on average in the successful groups, and approximately 60 weeks of relief in Group I and 54 weeks of relief in Group II at 2 years in the successful group. CONCLUSION: Caudal epidural injections of local anesthetic with or without steroids provide relief in a modest proportion of patients undergoing the treatment and may be considered as an effective treatment for a select group of patients who have chronic function-limiting low back and lower extremity pain secondary to central spinal stenosis.
背景:腰椎管狭窄症是老年人腰痛的最常见原因之一,可导致显著的残疾。尽管其发病率很高,但关于椎管狭窄症状治疗的文献却很少。包括手术在内的多种干预措施,以及硬膜外注射和粘连松解等介入技术,通常用于治疗与中央椎管狭窄相关的疼痛。然而,关于硬膜外注射治疗腰椎中央椎管狭窄的有效性,随机对照试验的文献很少。
目的:本研究旨在评估骶管硬膜外注射利多卡因(0.5%)或利多卡因(0.5%)加 1 毫升类固醇(6 毫克非颗粒倍他米松)对慢性腰痛相关的腰椎中央狭窄症的管理是否能有效缓解疼痛。
研究设计:随机、双盲、活性对照试验。
方法:100 名患者被随机分配到两组中的一组,其中一组患者接受骶管硬膜外注射局部麻醉剂(0.5%利多卡因),而另一组患者接受骶管硬膜外注射 0.5%利多卡因 9 毫升加 1 毫升类固醇,6 毫克(非颗粒倍他米松)。
结果评估:使用了多种结果评估指标,包括数字评分量表(NRS)、Oswestry 残疾指数 2.0(ODI)、就业状况和阿片类药物摄入量。在治疗后 3、6、12、18 和 24 个月进行评估。主要结果定义为疼痛缓解和残疾评分改善 50%或以上。将至少 3 周的缓解作为成功治疗的标准,将这些患者分为成功组和失败组。
结果:在成功组中,当参与者被分为成功组和失败组时,第 2 年结束时,组 I 中有 51%和组 II 中有 57%的患者出现显著的疼痛缓解和功能状态改善。然而,总体而言,在第 2 年结束时,组 I 中有 38%和组 II 中有 44%的患者出现了显著的疼痛缓解和功能状态改善(≥50%)。两组在第 2 年的总治疗次数均为 4 次,成功组的平均治疗次数为 5 次,在成功组中,组 I 的缓解期约为 60 周,组 II 的缓解期约为 54 周。
结论:骶管硬膜外注射局麻药加或不加类固醇可使一部分接受治疗的患者缓解疼痛,对于因中央椎管狭窄导致慢性功能受限的腰痛和下肢疼痛的特定患者群体,可考虑作为一种有效的治疗方法。
BMC Musculoskelet Disord. 2023-11-21
Int J Mol Sci. 2021-9-30